24
The ageing HIV population in Scotland: adults and children Lesley A Wallace Health Protection Scotland SHIVAG, Dunfermline, 26 th June 2015

Shivag june 2015 law_finalcopy2

Embed Size (px)

Citation preview

The ageing HIV population in

Scotland:adults and children

Lesley A WallaceHealth Protection Scotland

SHIVAG, Dunfermline, 26th June 2015

HIV infection in Scotland

• Outline: Adults• HIV landscape • HIV diagnoses• Treatment & Care• Late diagnoses

• Combined with age information

• Data on paediatric infection

HIV Landscape: Scotland 2014 Estimates

Annual Annual Death & Chronically New transmissions (MSM) Exported Infection Infected & Imported Infection

(High Prev. ountries)

?100 – 120 6450 ~350

Diagnosed Undiagnosed 4900 (76%) 1550 (24%)

In Specialist Care Not in Specialist Care 4100 (84%) 800 (16%) Treated Untreated 3650 (89%) 450 (11%)

Optimal Response* Suboptimal Response 3500 (96%) 150 (4%)

*Cases recording HIV viral load of 400 copies/ml or less at latest attendance

34% >50

33% >50

35% >50

HIV infected persons by transmission category and year of

report, Scotland, 1981-2014

Data source: HIV diagnoses database, Health Protection Scotland

0

50

100

150

200

250

300

350

400

450

500

Nu

mb

er

Year

MSM

Heterosexual

PWID

Other/not known

Total

Reports of HIV infection – age at diagnosis, 2005-2014

• Most diagnoses in 25-49 age group

• Small increase in proportion of those aged 50+

0

20

40

60

80

100

120

140

160

2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Nu

mb

er

Year

15-24 25-34 35-49 50+

Current ages of HIV cohort living in Scotland

0

200

400

600

800

1000

1200

1400

1600

1800

2000

<20 20-29 30-39 40-49 50-59 60-69 >70

Nu

mb

er

Age group

• 36% of cohort aged 40-49• 1.6% over 70 – this includes those >80• 34% of cohort >50 years• People living with HIV in Scotland for >30 years

Current ages of HIV cohort in Scotland by transmission category

Data: HIV positive individuals alive and not known to have left Scotland at 31st December 2014

0

250

500

750

1000

1250

1500

1750

2000

2250

Women Men Heterosexual women

Heterosexual men

PWID women PWID men MSM

Num

ber

Exposure category

15-24 25-34

35-44 45+

Reports of heterosexually acquired HIV infection, Scotland, 2000-2014

0

20

40

60

80

100

120

140

160

180

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Nu

mb

er

Year

Non-UK nationals infected outwith the UK Non-UK nationals infected within the UK

UK Nationals infected within the UK UK Nationals infected outwith the UK

50% attending services are >45years, of this group:• 58% infected UK & 42% sub-Saharan Africa• 59% White UK/Ireland ethnicity & 32% Black African• 54% men

HIV reports among people who inject drugs (PWID), Scotland 1984-2014

2015 Cluster in Glasgow: 17 cases

• similar strain of virus

• Evidence of recent infection

• Many homeless

• Epidemiological links between cases

• Public health action

70% attending services are >45years

HIV reports among MSM, Scotland 1984-2014

53% attending services are >45years

HIV: Evidence of transmission• Testing of new ‘first time’ reports in Scotland• Recency of infection

– Avidity test results– Acquired infection within past 3-4m

MSM Other All

2012 17% 0% 11%

2013 21% 6% 14%

2014 30% 15% 21%

Most recent infections in MSM are aged 25-34y

HIV diagnoses, AIDS registrations and deaths and individuals undergoing CD4 monitoring by year of report/death in

Scotland, 1992-2014

Deaths data 2011-2014: 102 of 145 (70%) are aged >45

- 1ry cause for all ages: 35% HIV related and15% malignancies

- 32% with AIDS registration at some time

0

500

1000

1500

2000

2500

3000

3500

4000

4500

0

50

100

150

200

250

300

350

400

450

500

Nu

mb

er

un

derg

oin

g H

IV m

on

ito

rin

g

Nu

mb

er

Year

HIV diagnoses AIDS registrations Deaths

AIDS deaths CD4 Persons monitored

Combination therapy available 1996

HIV Landscape: Scotland 2014 Estimates

Annual Annual Death & Chronically New transmissions (MSM) Exported Infection Infected & Imported Infection

(High Prev. ountries)

?100 – 120 6450 ~350

Diagnosed Undiagnosed 4900 (76%) 1550 (24%)

In Specialist Care Not in Specialist Care 4100 (84%) 800 (16%) Treated Untreated 3650 (89%) 450 (11%)

Optimal Response* Suboptimal Response 3500 (96%) 150 (4%)

*Cases recording a “managable” HIV viral load of 400 copies/ml or less at latest attendance

34% >50

33% >50

35% >50

Number predicted to be receiving HIV treatment and care,Scotland,2020

S. Corson et al, BASHH, Glasgow 2015

Model predicts: - 40% increase in those in care - 50% increase in those receiving treatment

START – Scotland perspective

• 1539 individuals attending for the first time AND starting treatment for the first time between 2000 -2011

• CD4 count up to 90 days before first recorded treatment– 19% started treatment CD4 >350

• Outcome: proportion of deaths– 6.6% in those treated at CD4 <350– 3.7% in those treated at CD4 >350

CD4 count pre

treatmentNumber

Number of deaths

Proportion (%)

<200 739 70 9.5

201-350 503 12 2.4

350-500 192 8 4.2

>500 105 3 2.9

HIV - late diagnosis

• Late diagnosis: CD4 count <350*

* CD4 cell count <350 within 30 days of earliest positive HIV diagnosis , excludes those known to be previously infected

0

10

20

30

40

50

60

70

80

90

100

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Pro

po

rtio

n (

%)

Year

% 201-350

% <200

0

10

20

30

40

50

60

70

80

90

100

2012 2013 2014 2012 2013 2014

Pro

port

ion

%

Year

<30 years 31-50 years >50 years

Heterosexual MSM

• Age comparisons: no evidence that more late diagnoses are made in older people

HIV infection among children in Scotland

HIV infection among children•126 paediatric HIV infections notified to HPS

•73 males and 53 females • 58% UK born • 39% Black African ethnicity• Transmission routes:

96

22

6 2

Mother-to-child transmission

Blood factor treatment

Blood/tissue transfer

Other/undetermined

Data source: Laboratory reports of newly diagnosed HIV positive individuals aged > 18m and *NSHPC- National Study of HIV in Pregnancy and Childhood

UK*: ~2570• 84% MTCT• 40% UK born•15% died

HIV diagnoses among children by year of report and transmission category,

Scotland, 1982-2014

Data source: Integrated HIV & AIDS Diagnoses Surveillance System

0

1

2

3

4

5

6

7

8

9

10

11

12

1982 1984 1986 1989 1991 1994 1998 2001 2003 2005 2007 2009 2011 2013

Num

ber

Year

Blood/Tissue transfer Blood factor treatment Mother to child Other/Unknown

HIV antibody test available

Antenatal screening

HIV diagnoses among children by ethnicity and year of

report,Scotland, 1982-2014

Data source: Integrated HIV & AIDS Diagnoses Surveillance System

0

2

4

6

8

10

12

14

16

1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014

Num

ber

Year

Black-African Mixed White-Scottish

White-Other White-Other British Other/Unk

Antenatal screening

Outcomes among paediatric HIV diagnoses

• Of 126 paediatric diagnoses:

• 29 (23%) have died

• median survival 5years (range 0-20years)

• 21 (72%) of these registered as having AIDS

• Of 97 HIV infected children alive at end 2014• 43 attending for treatment and care• 30 are <15 years• 18 lost to follow up• 6 left ScotlandData source: Integrated HIV & AIDS Diagnoses Surveillance System

Access to specialist care and therapy

• Of 43 paediatric HIV infections now attending for treatment and care:

- aged 16-46years (median 24y) - 93% (40) on antiviral therapy

- 93% (37) achieved viral suppression - 67% UK born - 26% Black African

UK*: 1037 in treatment and care • 48% UK born• 79% Black African• 97% Mother to child transmission

• 84% on ART (11% naive and 5% off ART)* CHIPS data to end March 2014

Summary• Estimated 6450 living with HIV in Scotland

– 4900 diagnosed

• Ongoing HIV transmission

• Late diagnosis

• High proportion of cohort accessing specialist care and responding to treatment

• Diagnosis of HIV among children in Scotland is rare event - mostly imported infection

• Ageing cohort – further analyses?– use morbidity data?– survival analyses?

Acknowledgements

with thanks to data suppliers…AIDS & HIV Clinicians, Nurses, GUM clinic staff, Co-ordinators,and Collaborators

& Laboratory staff throughout Scotland

& Colleagues at HPS